查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526895

2024 年生物防禦全球市場報告

Biodefense Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

生物防禦市場規模預計在未來幾年將強勁成長。 2028年將以9.2%的年複合成長率（CAGR）成長至263.8億美元。預計的成長因素包括新感染疾病的出現、生物技術的進一步進步、支持全球生物防禦努力的更強力的國際合作和資金籌措機制、生物防禦基礎設施的加強和現代化、公眾意識和教育的提高、政策和法律規範。預測期內預計的主要趨勢包括在預測建模、威脅檢測和創建新的生物防禦工具、遠端醫療和遠端監控中利用人工智慧和機器學習來早期檢測和管理生物威脅，其中包括技術整合，重點是資料主導技術。

由於新興感染疾病的持續威脅，生物防禦市場預計將成長。這些疾病由細菌、病毒、寄生蟲和真菌等多種微生物引起，凸顯了生物防禦領域病原體控制、快速反應策略、全球協調和準備的持續挑戰。生物防禦對於透過改善對生物威脅的準備、早期發現和快速反應來控制感染疾病和減少其對公共衛生的影響至關重要。例如，2023年11月，世界衛生組織（WHO）估計，2022年，全球將有約1,060萬結核病患者，影響全球數百萬人。這些反覆出現的威脅正在推動生物防禦市場的成長。

生物防禦領域的主要企業正在積極開發創新解決方案，例如 COVID-19經鼻吸入型疫苗，以加強世界對生物危害的準備。經鼻吸入型疫苗的優點包括給藥方便、黏膜免疫潛力、減少對針頭的依賴、增加可用性以及增強免疫反應的潛力。例如，Bharat Biotech International Limited於2023年1月推出了COVID-19經鼻吸入型疫苗iNCOVACC。該疫苗是使用攜帶預融合穩定刺突蛋白的重組複製缺陷型腺病毒載體開發的，並成功通過了 I、II 和 III 期試驗。它以滴鼻劑的形式給藥，分兩次給藥，間隔 4 週，每個鼻孔滴 4 滴。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球生物防禦市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球生物防禦市場表現：規模與成長，2018-2023
  • 全球生物防禦市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球生物防禦市場：按類型、實際和預測分類，2018-2023、2023-2028、2033
  • 炭疽菌
  • 天花
  • 肉毒中毒
  • 輻射還是核？
  • 其他類型
  • 全球生物防禦市場：生物威脅偵測設備的性能與預測，2018-2023、2023-2028、2033
  • 採樣器
  • 檢測器或觸發裝置
  • 識別符
  • 化驗
  • 其他生物威脅偵測裝置
  • 全球生物防禦市場：按應用、性能和預測，2018-2023、2023-2028、2033
  • 醫院和診所
  • 門診治療中心
  • 其他用途

第 7 章 區域/國家分析

  • 全球生物防禦市場：按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球生物防禦市場：依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 生物防禦市場：競爭格局
  • 生物防禦市場：公司簡介
    • Pfizer Inc.
    • Johnson & Johnson
    • Merck & Co.
    • Sanofi SA
    • Bristol-Myers Squibb Company

第31章 其他重大及創新企業

  • AstraZeneca Plc
  • GSK plc
  • Gilead Sciences Inc
  • Biogen Inc
  • Novavax Inc
  • Ichor Medical Systems
  • Emergent BioSolutions Inc.
  • Alnylam Pharmaceuticals Inc.
  • Dynavax Technologies
  • Bavarian Nordic
  • Siga Technologies Inc.
  • Elusys Therapeutics Inc.
  • Ology Bioservices
  • Altimmune Inc.
  • Hytest Limited

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18544

Biodefense encompasses strategies and measures aimed at safeguarding against biological threats, including intentional releases of pathogens or biotoxins. These efforts involve developing detection systems, vaccines, treatments, and emergency response plans to minimize the impact of biological attacks on public health and safety. Additionally, biodefense includes research and policies to prevent the misuse of biological agents.

The primary types of biodefense include anthrax, smallpox, botulism, radiation or nuclear threats, and others. Anthrax is a severe infectious disease caused by Bacillus anthracis, affecting humans and animals. It can be contracted through skin contact, inhalation, or ingestion of spores. Various biothreat detection devices, such as samplers, detectors, identifiers, assays, and more, are utilized in settings such as hospitals, clinics, ambulatory care centers, and beyond.

The biodefense research report is one of a series of new reports from The Business Research Company that provides biodefense market statistics, including the biodefense industry's global market size, regional shares, competitors with a biodefense market share, detailed biodefense market segments, market trends and opportunities, and any further data you may need to thrive in the biodefense industry. This biodefense market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biodefense market size has grown strongly in recent years. It will grow from $17.01 billion in 2023 to $18.55 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The historic period's growth can be attributed to heightened government investment in biodefense programs and initiatives, bolstering regulatory frameworks to expedite biodefense product and technology approvals, improved collaboration among government agencies, private sector entities, and academic institutions, and mounting geopolitical tensions and apprehensions regarding bioterrorism.

The biodefense market size is expected to see strong growth in the next few years. It will grow to $26.38 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The forecasted growth can be attributed to several factors, the ongoing emergence of new infectious diseases, further advancements in biotechnology, strengthened international collaboration and funding mechanisms supporting global biodefense efforts, the enhancement and modernization of biodefense infrastructure, increased public awareness and education on biodefense matters, continual evolution of policies and regulatory frameworks to facilitate innovative biodefense technologies, and growing private sector investment in biodefense research and development. Major trends expected in the forecast period include the utilization of AI and machine learning for predictive modeling, threat detection, and the creation of new biodefense tools, integration of telehealth and remote monitoring technologies for early detection and management of biological threats, a focus on developing next-generation vaccines and therapeutics along with AI-driven drug discovery and development processes, and enhanced genomic surveillance and data analytics capabilities.

The biodefense market is anticipated to experience growth due to the persistent threat of emerging infectious diseases. These diseases, caused by various microorganisms such as bacteria, viruses, parasites, or fungi, highlight the ongoing challenges in pathogen control, rapid response strategies, global coordination, and readiness within the biodefense sector. Biodefense is crucial for managing infectious diseases by improving preparedness, early detection, and swift response to biological threats, thus mitigating their impact on public health. For example, in November 2023, the World Health Organization (WHO) estimated a global tuberculosis (TB) case count of around 10.6 million in 2022, affecting millions of individuals worldwide. This recurring threat underscores the driving force behind the growth of the biodefense market.

Leading companies in the biodefense sector are actively developing innovative solutions, such as nasal COVID-19 vaccines, to bolster global readiness against biological hazards. Nasal vaccines offer advantages such as easier administration, potential for mucosal immunity, reduced reliance on needles, increased accessibility, and potentially enhanced immune responses. For instance, Bharat Biotech International Limited launched the iNCOVACC Nasal COVID-19 vaccine in January 2023. This vaccine, developed using a recombinant replication-deficient adenovirus vector with a pre-fusion stabilized spike protein, underwent successful phase I, II, and III trials. Administered via nasal drops, it involves a 2-dose series given 4 weeks apart, with 4 drops into each nostril.

In September 2022, Emergent BioSolutions Inc. acquired worldwide rights to the TEMBEXA (brincidofovir) smallpox oral antiviral drug from Chimerix for $238 million. This acquisition underscores Emergent BioSolutions' commitment to advancing public health initiatives and addressing global health threats, particularly against smallpox outbreaks. Chimerix Inc., a biotechnology research company, is known for providing biodefense solutions.

Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals

North America was the largest region in the biodefense market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biodefense market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biodefense market consists of revenues earned by entities by providing services such as threat assessment, surveillance, training, consultation, strategy development, emergency planning, and facility management. The market value includes the value of related goods sold by the service provider or included within the service offering. The biodefense market also includes sales of detection equipment, personal protective gear, vaccines and pharmaceuticals, biological agent identification kits, biocontainment equipment, emergency response kits, biosecurity systems, and communication systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodefense Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biodefense market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodefense ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biodefense market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Anthrax; Smallpox; Botulism; Radiation Or Nuclear; Other Types
  • 2) By Biothreat Detection Device: Samplers; Detectors Or Triggering Devices; Identifiers; Assays; Other Biothreat Detection Devices
  • 3) By Application: Hospitals And Clinics; Ambulatory Care Centers; Other Applications
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co.; Sanofi SA; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biodefense Market Characteristics

3. Biodefense Market Trends And Strategies

4. Biodefense Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Biodefense Market Size and Growth

  • 5.1. Global Biodefense Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Biodefense Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Biodefense Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biodefense Market Segmentation

  • 6.1. Global Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anthrax
  • Smallpox
  • Botulism
  • Radiation Or Nuclear
  • Other Types
  • 6.2. Global Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Samplers
  • Detectors Or Triggering Devices
  • Identifiers
  • Assays
  • Other Biothreat Detection Devices
  • 6.3. Global Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Care Centers
  • Other Applications

7. Biodefense Market Regional And Country Analysis

  • 7.1. Global Biodefense Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Biodefense Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biodefense Market

  • 8.1. Asia-Pacific Biodefense Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biodefense Market

  • 9.1. China Biodefense Market Overview
  • 9.2. China Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biodefense Market

  • 10.1. India Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biodefense Market

  • 11.1. Japan Biodefense Market Overview
  • 11.2. Japan Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biodefense Market

  • 12.1. Australia Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biodefense Market

  • 13.1. Indonesia Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biodefense Market

  • 14.1. South Korea Biodefense Market Overview
  • 14.2. South Korea Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biodefense Market

  • 15.1. Western Europe Biodefense Market Overview
  • 15.2. Western Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biodefense Market

  • 16.1. UK Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biodefense Market

  • 17.1. Germany Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biodefense Market

  • 18.1. France Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biodefense Market

  • 19.1. Italy Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biodefense Market

  • 20.1. Spain Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biodefense Market

  • 21.1. Eastern Europe Biodefense Market Overview
  • 21.2. Eastern Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biodefense Market

  • 22.1. Russia Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biodefense Market

  • 23.1. North America Biodefense Market Overview
  • 23.2. North America Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biodefense Market

  • 24.1. USA Biodefense Market Overview
  • 24.2. USA Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biodefense Market

  • 25.1. Canada Biodefense Market Overview
  • 25.2. Canada Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biodefense Market

  • 26.1. South America Biodefense Market Overview
  • 26.2. South America Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biodefense Market

  • 27.1. Brazil Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biodefense Market

  • 28.1. Middle East Biodefense Market Overview
  • 28.2. Middle East Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biodefense Market

  • 29.1. Africa Biodefense Market Overview
  • 29.2. Africa Biodefense Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Biodefense Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biodefense Market Competitive Landscape And Company Profiles

  • 30.1. Biodefense Market Competitive Landscape
  • 30.2. Biodefense Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi SA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Biodefense Market Other Major And Innovative Companies

  • 31.1. AstraZeneca Plc
  • 31.2. GSK plc
  • 31.3. Gilead Sciences Inc
  • 31.4. Biogen Inc
  • 31.5. Novavax Inc
  • 31.6. Ichor Medical Systems
  • 31.7. Emergent BioSolutions Inc.
  • 31.8. Alnylam Pharmaceuticals Inc.
  • 31.9. Dynavax Technologies
  • 31.10. Bavarian Nordic
  • 31.11. Siga Technologies Inc.
  • 31.12. Elusys Therapeutics Inc.
  • 31.13. Ology Bioservices
  • 31.14. Altimmune Inc.
  • 31.15. Hytest Limited

32. Global Biodefense Market Competitive Benchmarking

33. Global Biodefense Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biodefense Market

35. Biodefense Market Future Outlook and Potential Analysis

  • 35.1 Biodefense Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Biodefense Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Biodefense Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer